These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4096529)

  • 1. Detection of complement activation in human serum using C5a-induced chemiluminescence of human granulocytes.
    Kapp A; Maly FE; Schöpf E
    Arch Dermatol Res; 1985; 278(1):41-3. PubMed ID: 4096529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different sensitivities of the responses of human neutrophils stimulated with immune complex and C5a anaphylatoxin to pertussis toxin.
    Shirato M; Takahashi K; Nagasawa S; Koyama J
    FEBS Lett; 1988 Jul; 234(1):231-4. PubMed ID: 2839363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a-induced chemiluminescence of human granulocytes and its amplification by a serum factor.
    Maly FE; Kapp A; Rother U
    Immunobiology; 1983 Feb; 164(1):90-7. PubMed ID: 6303949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eculizumab-C5 complexes express a C5a neoepitope in vivo: Consequences for interpretation of patient complement analyses.
    Nilsson PH; Thomas AM; Bergseth G; Gustavsen A; Volokhina EB; van den Heuvel LP; Barratt-Due A; Mollnes TE
    Mol Immunol; 2017 Sep; 89():111-114. PubMed ID: 28610663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.
    Larrick JW; Wang J; Fendly BM; Chenoweth DE; Kunkel SL; Deinhart T
    Infect Immun; 1987 Aug; 55(8):1867-72. PubMed ID: 2440808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive ELISA for the quantitation of human C5a in blood plasma using a monoclonal antibody.
    Schulze M; Götze O
    Complement; 1986; 3(1):25-39. PubMed ID: 3743034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validity of the granulocyte aggregation test for the evaluation of complement activation in the adult respiratory distress syndrome].
    Ortolani O; Conti A; Minale F; Imperatore R; Mazzarella L
    Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1207-14. PubMed ID: 4063110
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a.
    Watson WC; Cremer MA; Wooley PH; Townes AS
    Arthritis Rheum; 1986 Nov; 29(11):1316-21. PubMed ID: 3778540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.
    Williams JJ; Yellin SA; Slotman GJ
    Arch Surg; 1986 Mar; 121(3):305-7. PubMed ID: 3484946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.
    Akagaki Y; Inai S
    Mol Immunol; 1983 Nov; 20(11):1221-6. PubMed ID: 6419059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation.
    Hammerschmidt DE; Bowers TK; Lammi-Keefe CJ; Jacob HS; Craddock PR
    Blood; 1980 Jun; 55(6):898-902. PubMed ID: 6991024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of complement fragment C5a in milk is variable among cows.
    Rainard P; Poutrel B
    J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
    Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
    Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.
    Warren JS; Kunkel SL; Johnson KJ; Ward PA
    Am J Pathol; 1987 Dec; 129(3):578-88. PubMed ID: 2827492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.